Catalyst Pharmaceuticals (CPRX) Tops Q4 EPS by 26c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.49 -0.03%
EPS Growth %: -30.9%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
EPAC, SAR, KRUS, More
EPS Growth %: -30.9%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q4 EPS of $0.53, $0.26 better than the analyst estimate of $0.27. Revenue for the quarter came in at $110.57 million versus the consensus estimate of $106.13 million.
For earnings history and earnings-related data on Catalyst Pharmaceuticals (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
- Freedom Broker Starts PBF Energy (PBF) at Hold
- TRNR agrees to acquire STEPR, raises 2026 revenue guidance to $50M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
